62 studies found for:    Open Studies | "Eosinophilia"
Show Display Options
Rank Status Study
21 Recruiting Compassionate Use of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES)
Condition: Hypereosinophilic Syndrome
Intervention: Drug: mepolizumab
22 Recruiting Study to Image the Esophagus Using the OFDI Capsule
Conditions: Barrett's Esophagus;   Eosinophilic Esophagitis
Intervention: Device: OFDI Capsule
23 Recruiting Oral Cromolyn Sodium for the Treatment of Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Interventions: Drug: oral cromolyn sodium;   Drug: Placebo
24 Recruiting Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia
Conditions: Adult Acute Basophilic Leukemia;   Adult Acute Eosinophilic Leukemia;   Adult Acute Monoblastic Leukemia;   Adult Acute Monocytic Leukemia;   Adult Acute Myeloid Leukemia With Maturation;   Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL;   Adult Acute Myeloid Leukemia Without Maturation;   Adult Acute Myelomonocytic Leukemia;   Alkylating Agent-Related Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia;   Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: Daunorubicin Hydrochloride;   Drug: Cytarabine;   Drug: Decitabine;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
25 Unknown  Confocal Laser Endomicroscopy in Patients With Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis.
Intervention: Device: Confocal laser endomicroscopy
26 Not yet recruiting Diagnosis and Monitoring of Eosinophilic Esophagitis Using the Cytosponge
Conditions: Eosinophilic Esophagitis;   EoE
Intervention:
27 Recruiting Budesonide Versus Fluticasone for Treatment of Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Interventions: Drug: Oral Viscous Budesonide;   Drug: Fluticasone MDI;   Drug: Placebo slurry;   Drug: Placebo inhaler
28 Recruiting Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD
Conditions: Eosinophilic Esophagitis;   Connective Tissue Disorders
Intervention: Drug: Losartan Potassium
29 Recruiting Study of Dupilumab in Adult Patients With Active Eosinophilic Esophagitis (EoE)
Condition: Eosinophilic Esophagitis
Interventions: Drug: Dupilumab;   Drug: Placebo
30 Recruiting Improved Diagnostics of Celiac Disease in Children
Conditions: Celiac Disease;   Eosinophilic Esophagitis
Intervention:
31 Recruiting Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus
Condition: Eosinophilic Esophagitis
Intervention: Device: SECM Capsule
32 Recruiting Trial of Montelukast in Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Interventions: Drug: Montelukast/ Singulair;   Drug: Placebo
33 Recruiting EndoFLIP Use in Upper GI Tract Stenosis
Conditions: Esophageal Stricture;   Eosinophilic Esophagitis;   Zenkers Diverticulum;   Schatzki Ring
Intervention: Device: EndoFLIP
34 Unknown  Routine Screening for Eosinophilic Esophagitis in Patients Presenting With Dysphagia
Condition: Dysphagia
Intervention:
35 Recruiting EoE(Eosinophilic Esophagitis)
Conditions: Eosinophilic Esophagitis;   Dysphagia
Intervention: Procedure: Eosinophilic Esophagitis with Dysphagia
36 Recruiting Esophageal Motility in Eosinophilic Esophagitis Evaluated by High Resolution Manometry.
Condition: Eosinophilic Esophagitis
Intervention: Device: High resolution manometry (HRM)
37 Recruiting Mucosal Impedance in Pediatric Population
Conditions: Gastroesophageal Reflux Disease (GERD);   Eosinophilic Esophagitis (EoE);   Functional Dyspepsia
Intervention: Procedure: Standard of Care esophagogastroduodenoscopy (EGD) with mucosal impedance testing
38 Recruiting Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia
Conditions: Childhood Acute Basophilic Leukemia;   Childhood Acute Eosinophilic Leukemia;   Childhood Acute Erythroleukemia (M6);   Childhood Acute Megakaryocytic Leukemia (M7);   Childhood Acute Minimally Differentiated Myeloid Leukemia (M0);   Childhood Acute Monoblastic Leukemia (M5a);   Childhood Acute Monocytic Leukemia (M5b);   Childhood Acute Myeloblastic Leukemia With Maturation (M2);   Childhood Acute Myeloblastic Leukemia Without Maturation (M1);   Childhood Acute Myelomonocytic Leukemia (M4);   Recurrent Childhood Acute Myeloid Leukemia;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Intervention: Other: laboratory biomarker analysis
39 Recruiting Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant
Conditions: Accelerated Phase of Disease;   Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11;   Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11;   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1;   Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL;   Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA;   Alkylating Agent-Related Acute Myeloid Leukemia;   Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative;   Blastic Phase;   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Childhood Myelodysplastic Syndrome;   Chronic Eosinophilic Leukemia, Not Otherwise Specified;   Chronic Myelomonocytic Leukemia;   Chronic Neutrophilic Leukemia;   Chronic Phase of Disease;   de Novo Myelodysplastic Syndrome;   DS Stage I Plasma Cell Myeloma;   DS Stage II Plasma Cell Myeloma;   DS Stage III Plasma Cell Myeloma;   Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Nodal Marginal Zone Lymphoma;   Previously Treated Myelodysplastic Syndrome;   Primary Myelofibrosis;   Secondary Acute Myeloid Leukemia;   Secondary Myelodysplastic Syndrome;   Splenic Marginal Zone Lymphoma;   Stage II Adult Non-Contiguous Immunoblastic Lymphoma;   Stage II Grade 1 Non-Contiguous Follicular Lymphoma;   Stage II Grade 2 Non-Contiguous Follicular Lymphoma;   Stage II Grade 3 Non-Contiguous Follicular Lymphoma;   Stage II Marginal Zone Lymphoma;   Stage II Non-Contiguous Adult Burkitt Lymphoma;   Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma;   Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma;   Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma;   Stage II Non-Contiguous Adult Lymphoblastic Lymphoma;   Stage II Non-Contiguous Mantle Cell Lymphoma;   Stage II Small Lymphocytic Lymphoma;   Stage III Adult Burkitt Lymphoma;   Stage III Adult Diffuse Large Cell Lymphoma;   Stage III Adult Diffuse Mixed Cell Lymphoma;   Stage III Adult Diffuse Small Cleaved Cell Lymphoma;   Stage III Adult Hodgkin Lymphoma;   Stage III Adult Immunoblastic Lymphoma;   Stage III Adult Lymphoblastic Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Stage III Grade 1 Follicular Lymphoma;   Stage III Grade 2 Follicular Lymphoma;   Stage III Grade 3 Follicular Lymphoma;   Stage III Mantle Cell Lymphoma;   Stage III Marginal Zone Lymphoma;   Stage III Small Lymphocytic Lymphoma;   Stage IV Adult Burkitt Lymphoma;   Stage IV Adult Diffuse Large Cell Lymphoma;   Stage IV Adult Diffuse Mixed Cell Lymphoma;   Stage IV Adult Diffuse Small Cleaved Cell Lymphoma;   Stage IV Adult Hodgkin Lymphoma;   Stage IV Adult Immunoblastic Lymphoma;   Stage IV Chronic Lymphocytic Leukemia;   Stage IV Grade 1 Follicular Lymphoma;   Stage IV Grade 2 Follicular Lymphoma;   Stage IV Grade 3 Follicular Lymphoma;   Stage IV Mantle Cell Lymphoma;   Stage IV Marginal Zone Lymphoma;   Stage IV Small Lymphocytic Lymphoma
Interventions: Drug: Pentostatin;   Biological: Therapeutic Allogeneic Lymphocytes;   Drug: Mycophenolate Mofetil;   Drug: Cyclosporine
40 Not yet recruiting Mometasone-furoate for Treatment of Eosinophilic Esophagitis - a Randomized Placebo Controlled Study.
Condition: Eosinophilic Esophagitis
Intervention: Drug: Mometasone furoate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years